Balchem Corp (BCPC) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Record Earnings

GuruFocus.com10-26

Revenue: $240 million, up 4.3% year-over-year. Gross Margin: 35.6%, an increase of 230 basis points. Earnings from Operations: $48 million, up 10% year-over-year. Adjusted EBITDA: $64 million, up 7.6%...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2478923412?lang=en_US&edition=fundamental","thumbnail":"https://s.yimg.com/uu/api/res/1.2/ZeZv0Mz7HW7Z_DY6Dgahyg--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/0607192003cc187ae62db39d1dba642d","is_english":true,"pubTime":"2024-10-26 19:00","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2478923412","market":"us","top_or_hot":-1,"title":"Balchem Corp (BCPC) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Record Earnings","media":"GuruFocus.com","content":"<div>\n<p>Revenue: $240 million, up 4.3% year-over-year.\nGross Margin: 35.6%, an increase of 230 basis points.\nEarnings from Operations: $48 million, up 10% year-over-year.\nAdjusted EBITDA: $64 million, up 7.6%...</p>\n\n<a href=\"https://finance.yahoo.com/news/balchem-corp-bcpc-q3-2024-110030866.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Balchem Corp (BCPC) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Record Earnings</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBalchem Corp (BCPC) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Record Earnings\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-10-26 19:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/balchem-corp-bcpc-q3-2024-110030866.html><strong>GuruFocus.com</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Revenue: $240 million, up 4.3% year-over-year.\nGross Margin: 35.6%, an increase of 230 basis points.\nEarnings from Operations: $48 million, up 10% year-over-year.\nAdjusted EBITDA: $64 million, up 7.6%...</p>\n\n<a href=\"https://finance.yahoo.com/news/balchem-corp-bcpc-q3-2024-110030866.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BCPC","symbol_name":"拜切","start_time":0,"source_url":"https://finance.yahoo.com/news/balchem-corp-bcpc-q3-2024-110030866.html","article_id":"2478923412","we_media_id":null,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/ZeZv0Mz7HW7Z_DY6Dgahyg--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/0607192003cc187ae62db39d1dba642d"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2478923412","pubTimestamp":1729940430,"columns":[],"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"Gross Margin: 35.6%, an increase of 230 basis points.Earnings from Operations: $48 million, up 10% year-over-year.Adjusted EBITDA: $64 million, up 7.6% with a margin of 26.8%.Adjusted Net Earnings: $37 million, up 9.3% with EPS of $1.13.Human Nutrition and Health Segment Sales: $152 million, up 5.4% year-over-year.Animal Nutrition and Health Segment Sales: $53 million, down 1.9% year-over-year.Specialty Product Segment Sales: $33 million, up 10.6% year-over-year.Net Debt: Reduced by $40 million, ending at $153 million.GuruFocus has detected 6 Warning Sign with BCPC.For the complete transcript of the earnings call, please refer to the full earnings call transcript.Balchem Corp  reported strong third quarter financial results with a 4.3% increase in consolidated revenues, reaching $240 million.The company achieved record earnings from operations of $48 million, a 10% increase compared to the prior year.Record quarterly adjusted EBITDA of $64 million was reported, marking a 7.6% increase ","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"BCPC":"拜切"},"translate_title":"Balchem Corp(BCPC)2024年第三季度收益看涨期权亮点：强劲的收入增长和创纪录的收益","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BCPC":1},"content_text":"Revenue: $240 million, up 4.3% year-over-year.\nGross Margin: 35.6%, an increase of 230 basis points.\nEarnings from Operations: $48 million, up 10% year-over-year.\nAdjusted EBITDA: $64 million, up 7.6% with a margin of 26.8%.\nNet Income: $34 million, up 16.4% year-over-year.\nEarnings Per Share (GAAP): $1.03.\nAdjusted Net Earnings: $37 million, up 9.3% with EPS of $1.13.\nCash Flow from Operations: $51 million.\nFree Cash Flow: $42 million.\nHuman Nutrition and Health Segment Sales: $152 million, up 5.4% year-over-year.\nAnimal Nutrition and Health Segment Sales: $53 million, down 1.9% year-over-year.\nSpecialty Product Segment Sales: $33 million, up 10.6% year-over-year.\nNet Debt: Reduced by $40 million, ending at $153 million.\nEffective Tax Rate: 22.9% for Q3 2024.\n\n\nWarning! GuruFocus has detected 6 Warning Sign with BCPC.\n\nRelease Date: October 25, 2024\nFor the complete transcript of the earnings call, please refer to the full earnings call transcript.\n Positive Points \n\nBalchem Corp (NASDAQ:BCPC) reported strong third quarter financial results with a 4.3% increase in consolidated revenues, reaching $240 million.\nThe company achieved record earnings from operations of $48 million, a 10% increase compared to the prior year.\nRecord quarterly adjusted EBITDA of $64 million was reported, marking a 7.6% increase with an adjusted EBITDA margin of 26.8%.\nThe human nutrition and health segment showed excellent performance, contributing significantly to the company's growth.\nBalchem Corp (NASDAQ:BCPC) launched several innovative products, including Amina Sure XL and K2 Vital Delta, which are expected to support future growth.\n\n Negative Points \n\nThe animal nutrition and health segment experienced softness, with a 1.9% decrease in sales compared to the prior year.\nOperating expenses increased to $37 million from $33 million in the prior year, primarily due to higher compensation-related costs and transaction charges.\nThe European animal feed market remains challenging, with continued competition from low-cost imports affecting sales.\nThe effective tax rate increased to 22.9% from 20.3% in the prior year, due to lower tax benefits from stock-based compensation and higher state taxes.\nDespite improvements, the animal nutrition and health segment has not yet returned to healthy demand levels.\n\n Q & A Highlights \nQ: Can you tell us more about your product development process, where you get your ideas from, and the pipeline for new products? A: Theodore Harris, Chairman, President, and CEO, explained that Balchem's product development process is a blend of in-house development and customer input. The process typically takes about a year, sometimes longer, and involves significant marketing efforts. The company has been investing in marketing and R&D to bring more products to market, resulting in recent successful launches.\nQ: What is the outlook for the minerals and nutrition subsegment in Human Nutrition and Health (H&H)? A: Theodore Harris noted that the minerals and nutrients business has been strong and is expected to continue growing, albeit at a slower pace due to tougher year-over-year comparisons. The food business is expected to accelerate its growth as market conditions improve.\nQ: How have dairy farmers reacted to the rebound in milk prices in terms of demand for your products? A: Martin Bengtsson, CFO, stated that improved milk prices and lower feed costs have led to increased demand for Balchem's feed additives and encapsulated nutrients. The company is seeing positive trends in order books, indicating a healthier market outlook.\nQ: How do you anticipate allocating capital for commercial support of H&H assets, and what is your strategy regarding anti-aging and weight loss markets? A: Theodore Harris mentioned that Balchem plans to increase spending on marketing and R&D, particularly in H&H. The company is exploring social media marketing and sees opportunities in anti-aging, which aligns with their product offerings. Weight loss is not a primary focus, but there is potential for ancillary roles in this market.\nQ: What are your thoughts on the M&A market and potential uses of cash if no opportunities arise? A: Martin Bengtsson indicated that the M&A market is improving, with more deal flow expected in 2025. If no M&A opportunities arise, Balchem may consider stock buybacks to return value to shareholders, maintaining their capital allocation philosophy of prioritizing organic growth, M&A, and dividends.\nFor the complete transcript of the earnings call, please refer to the full earnings call transcript.This article first appeared on \nGuruFocus.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2478923412"}